Literature DB >> 21921835

SvO(2)-guided resuscitation for experimental septic shock: effects of fluid infusion and dobutamine on hemodynamics, inflammatory response, and cardiovascular oxidative stress.

André Loureiro Rosário1, Marcelo Park, Milena Karina Brunialti, Marialice Mendes, Marjorie Rapozo, Denise Fernandes, Reinaldo Salomão, Francisco Rafael Laurindo, Guilherme Paula Schettino, Luciano Cesar P Azevedo.   

Abstract

The pathogenetic mechanisms associated to the beneficial effects of mixed venous oxygen saturation (SvO(2))-guided resuscitation during sepsis are unclear. Our purpose was to evaluate the effects of an algorithm of SvO(2)-driven resuscitation including fluids, norepinephrine and dobutamine on hemodynamics, inflammatory response, and cardiovascular oxidative stress during a clinically resembling experimental model of septic shock. Eighteen anesthetized and catheterized pigs (35-45 kg) were submitted to peritonitis by fecal inoculation (0.75 g/kg). After hypotension, antibiotics were administered, and the animals were randomized to two groups: control (n = 9), with hemodynamic support aiming central venous pressure 8 to 12 mmHg, urinary output 0.5 mL/kg per hour, and mean arterial pressure greater than 65 mmHg; and SvO(2) (n = 9), with the goals above, plus SvO(2) greater than 65%. The interventions lasted 12 h, and lactated Ringer's and norepinephrine (both groups) and dobutamine (SvO(2) group) were administered. Inflammatory response was evaluated by plasma concentration of cytokines, neutrophil CD14 expression, oxidant generation, and apoptosis. Oxidative stress was evaluated by plasma and myocardial nitrate concentrations, myocardial and vascular NADP(H) oxidase activity, myocardial glutathione content, and nitrotyrosine expression. Mixed venous oxygen saturation-driven resuscitation was associated with improved systolic index, oxygen delivery, and diuresis. Sepsis induced in both groups a significant increase on IL-6 concentrations and plasma nitrate concentrations and a persistent decrease in neutrophil CD14 expression. Apoptosis rate and neutrophil oxidant generation were not different between groups. Treatment strategies did not significantly modify oxidative stress parameters. Thus, an approach aiming SvO(2) during sepsis improves hemodynamics, without any significant effect on inflammatory response and oxidative stress. The beneficial effects associated with this strategy may be related to other mechanisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921835     DOI: 10.1097/SHK.0b013e3182336aa4

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  12 in total

Review 1.  Intravenous fluid therapy in sepsis.

Authors:  Kevin P Seitz; Edward T Qian; Matthew W Semler
Journal:  Nutr Clin Pract       Date:  2022-07-08       Impact factor: 3.204

Review 2.  Early Liberal Fluid Therapy for Sepsis Patients Is Not Harmful: Hydrophobia Is Unwarranted but Drink Responsibly.

Authors:  Anja K Jaehne; Emanuel P Rivers
Journal:  Crit Care Med       Date:  2016-12       Impact factor: 7.598

3.  Short-term effects of stored homologous red blood cell transfusion on cardiorespiratory function and inflammation: an experimental study in a hypovolemia model.

Authors:  S Biagini; C S Dale; J M Real; E S Moreira; C R R Carvalho; G P P Schettino; S Wendel; L C P Azevedo
Journal:  Braz J Med Biol Res       Date:  2017-11-17       Impact factor: 2.590

Review 4.  Early outcome of early-goal directed therapy for patients with sepsis or septic shock: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Xiaofan Chen; Weifeng Zhu; Jing Tan; Heyun Nie; Liangming Liu; Dongmei Yan; Xu Zhou; Xin Sun
Journal:  Oncotarget       Date:  2017-04-18

5.  Determinants of oxygen and carbon dioxide transfer during extracorporeal membrane oxygenation in an experimental model of multiple organ dysfunction syndrome.

Authors:  Marcelo Park; Eduardo Leite Vieira Costa; Alexandre Toledo Maciel; Débora Prudêncio E Silva; Natalia Friedrich; Edzangela Vasconcelos Santos Barbosa; Adriana Sayuri Hirota; Guilherme Schettino; Luciano Cesar Pontes Azevedo
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

6.  Increasing mean arterial blood pressure in sepsis: effects on fluid balance, vasopressor load and renal function.

Authors:  Thiago Domingos Corrêa; Madhusudanarao Vuda; Jukka Takala; Siamak Djafarzadeh; Eliézer Silva; Stephan Mathias Jakob
Journal:  Crit Care       Date:  2013-01-30       Impact factor: 9.097

7.  Factors associated with blood oxygen partial pressure and carbon dioxide partial pressure regulation during respiratory extracorporeal membrane oxygenation support: data from a swine model.

Authors:  Marcelo Park; Pedro Vitale Mendes; Eduardo Leite Vieira Costa; Edzangela Vasconcelos Santos Barbosa; Adriana Sayuri Hirota; Luciano Cesar Pontes Azevedo
Journal:  Rev Bras Ter Intensiva       Date:  2016 Jan-Mar

8.  Metabolic acid-base adaptation triggered by acute persistent hypercapnia in mechanically ventilated patients with acute respiratory distress syndrome.

Authors:  Thiago Gomes Romano; Mario Diego Teles Correia; Pedro Vitale Mendes; Fernando Godinho Zampieri; Alexandre Toledo Maciel; Marcelo Park
Journal:  Rev Bras Ter Intensiva       Date:  2016 Jan-Mar

Review 9.  Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE.

Authors:  H Bryant Nguyen; Anja Kathrin Jaehne; Namita Jayaprakash; Matthew W Semler; Sara Hegab; Angel Coz Yataco; Geneva Tatem; Dhafer Salem; Steven Moore; Kamran Boka; Jasreen Kaur Gill; Jayna Gardner-Gray; Jacqueline Pflaum; Juan Pablo Domecq; Gina Hurst; Justin B Belsky; Raymond Fowkes; Ronald B Elkin; Steven Q Simpson; Jay L Falk; Daniel J Singer; Emanuel P Rivers
Journal:  Crit Care       Date:  2016-07-01       Impact factor: 9.097

10.  Comparison of oxidative stress under different propofol administration protocols in Thoroughbred racehorses by bOS and bAP assessment.

Authors:  Yoshinori Kambayashi; Nao Tsuzuki; Hirotaka Tokushige; Kanichi Kusano
Journal:  J Equine Sci       Date:  2018-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.